Capital Wealth
TUE CLOSE · OCT 27   S&P 500 7,722.60 ▲0.60%  ·  DJIA 52,377.57 ▲0.03%  ·  NASDAQ 26,477.81 ▲1.18%  ·  10-YR 4.99%  ·  2-YR 4.74%  ·  WTI (DEC) $99.90 ▼1.83%  ·  GOLD $4,058.80 ▲0.91%  ·  VIX 17.52 ▼4.73%
Personal Journal · Wellness · Health Costs

Christina Applegate never had MS. An estimated 15% of MS diagnoses are wrong, and a wrong label costs real money

The actress was diagnosed in 2021 and became a voice for people with MS. Last week she said new tests show she never had it, and she still doesn't know what she has.

By Sean Anees Saifi · Capital Wealth · Published Wednesday, October 28, 2026 · Source: The Wall Street Journal, Monday, October 26, 2026, whose market figures are the Friday, October 23 close (Personal Journal)
Key Points
15%
estimated MS misdiagnosis rate, meta-analysis of six studies
2021
the year Applegate was diagnosed with MS
5 years
since her symptoms began, and still no answer
~1 million
people in the U.S. with MS, women most at risk
An amber pill bottle with a blank cream label stands on a folded paper beside a pair of tortoiseshell glasses on a granite kitchen counter, soft window light.
There's no single blood test for MS, which is why a wrong label can stick for years.
In one line: A famous MS diagnosis turned out to be wrong, and an estimated 15% are, so get a second look before a label drives your money decisions.

Christina Applegate was in tears last week on the podcast she co-hosts. She had news. After five years of numbness and pain, and a diagnosis of multiple sclerosis in 2021, her doctor ran new tests. She doesn't have MS. She never did. “I haven't gotten better,” she said. She's back at square one, and she still doesn't know what's wrong. Sara Ashley O'Brien told the story in the Journal's Wellness column on Monday.

Her case isn't rare. One meta-analysis, a study that pools other studies, combined six of them. It put the MS misdiagnosis rate at an estimated 15%. Other studies land higher or lower. The reason is simple. There's no single blood test for MS. Doctors look for a mix of symptoms and the lesions MS leaves on a brain and spine MRI. If that picture isn't clear, they check spinal fluid and other clues. Nearly one million Americans have MS, and women are the most at risk.

Plenty of other things look like MS. Migraines, blood-vessel disease, fibromyalgia, lupus and rare immune or genetic conditions can all mimic it. The treatments are different. So a person with the wrong label gets drugs for a disease she doesn't have. She also loses years she could've spent finding the real one. Dr. Tanuja Chitnis of Mass General Brigham told the Journal the fine print is exclusion. Before you call it MS, you rule out every other reasonable cause.

The label has a price

Dr. Michael Kornberg of Johns Hopkins made a point that goes past medicine. A label brings some comfort, he said. You know what's going on with your body. Take it away after five years, and that's hard to bear. Applegate's news may push other patients to question their own diagnoses. That's not a bad thing.

Our read

We file this under Health Costs, with a side of Insurance (M11). A big diagnosis changes the money plan fast. It can set off years of expensive drugs and scans. It can start a disability claim at work or on a private policy. It can change a life insurance application, a long-term care policy and a retirement date. Every one of those decisions rests on the label being right. For MS, an estimated 15% of the time it isn't. So when a diagnosis is going to steer big money, ask for a second opinion first. Ask a specialist at a different hospital, before the first expensive prescription. And ask again every few years. Tests improve. Applegate's doctor got there with newer tests.

The one thing in your plan this touches is your disability coverage. Pull the policy and read how it defines a disability and what a changed diagnosis does to a claim. The check this week is a phone call. If anyone in your house carries a lifelong diagnosis that drives spending, ask that doctor when it was last re-evaluated. Bring the answer to your next review. We'd rather fix the roof while it's sunny.

What It Means For Your Portfolio

Watch. Get a second opinion before the label spends your money

No portfolio action. The planning point is that a diagnosis drives money decisions, so verify it before it steers insurance, work and spending.

General planning principles, not advice for anyone in particular. For any lifelong diagnosis, get a second opinion from a specialist at a different center before the first costly treatment. Keep every test result in one folder, dated. Ask about a re-evaluation every few years as testing improves.

Before filing a disability claim, read what the policy says about a changed diagnosis. A wrong label can delay the right care and the right benefit.

Book a 15-Minute Review → Back to Edition No. 189 →